| 1 | p38α Inhibitor and PRMT1 Activator Combination to Restore Physiological TDP-43… h-ccc05373 | MAPK14/PRMT1 | validated | 0.895 | 2026-05-16 | Open → |
| 2 | HSPB1 Phosphorylation Mimetics to Promote Protective TDP-43 Liquid-Liquid Phase… h-ff0d545d | HSPB1 | validated | 0.820 | 2026-05-14 | Open → |
| 3 | CLU/APOE Duality in Amyloid Clearance Determines Cell-Type-Specific Vulnerabili… h-0bcda2e0 | APOE, CLU | validated | 0.811 | 2026-05-13 | Open → |
| 4 | Integrated Biomarker Panel for Therapeutic Window Identification h-ecd9ed6c | CHI3L1 | promoted | 0.784 | 2026-05-13 | Open → |
| 5 | TREM2-mediated microglial tau clearance enhancement SDA-2026-04-02-gap-tau-prop-20260402003221-H002 | TREM2 | proposed | 0.780 | 2026-05-16 | Open → |
| 6 | TREM2 Agonism to Restore Microglial Phagocytosis Across Both Pathologies h-15a8468c | TREM2, TYROBP (DAP12), PLCG2, SYK | promoted | 0.735 | 2026-05-16 | Open → |
| 7 | Microglial TREM2-Complement Axis Modulation h-3616325a | TREM2 and C3 | promoted | 0.726 | 2026-05-13 | Open → |
| 8 | ASO-Mediated Exon Skipping to Restore FUS-TAZ Chaperone Axis h-6756097b | FUS | promoted | 0.720 | 2026-05-16 | Open → |
| 9 | Early Proteasome Restoration Therapy h-9588dd18 | PSMC | promoted | 0.712 | 2026-05-13 | Open → |
| 10 | Ferroptosis Inhibition for α-Synuclein Neuroprotection h-2c776894 | GPX4 | promoted | 0.705 | 2026-05-13 | Open → |
| 11 | H2: Indole-3-Propionate (IPA) as the Actual Neuroprotective Effector h-66078909 | PXR (NR1I2), IDO1 | promoted | 0.699 | 2026-05-13 | Open → |
| 12 | TFEB-Independent Autophagy Bypass h-1e4bba56 | ULK1 | promoted | 0.697 | 2026-05-13 | Open → |
| 13 | cGAS-STING Senescence Circuit Disruption h-bbe4540f | CGAS, STING1 | promoted | 0.691 | 2026-05-13 | Open → |
| 14 | Multi-Target Synergy via Presynaptic Vesicle Hub Convergence h-2651ca91 | TH, VMAT2, DAT, GCH1, BDNF, SNCA (presynaptic hub) | proposed | 0.683 | 2026-05-14 | Open → |
| 15 | Astrocyte-Selective APOE4 Silencing via Lipid Nanoparticles h-541d61c3 | APOE4 | promoted | 0.682 | 2026-05-13 | Open → |
| 16 | HDAC6 Activation as SCFA-Mediated Neuroprotective Mechanism h-ca454967 | HDAC6, HSP90AA1 | proposed | 0.682 | 2026-05-14 | Open → |
| 17 | CRISPR-Mediated Mitochondrial Genome Editing for Complex I Dysfunction h-420db533 | MT-ND1, MT-ND4, MT-ND6 | proposed | 0.681 | 2026-05-13 | Open → |
| 18 | Cell-Type Specific TFEB Modulation h-b9acf0c9 | TFEB | promoted | 0.677 | 2026-05-13 | Open → |
| 19 | White Matter Oligodendrocyte Protection via CXCL10 Inhibition h-724e3929 | CXCL10 | promoted | 0.675 | 2026-05-13 | Open → |
| 20 | Dissociating SCFA's Dual Signaling Through GPR43/GPR41 Biased Agonism h-ded1734f | FFAR2, FFAR3, NLRP3 | promoted | 0.670 | 2026-05-14 | Open → |
| 21 | White Matter Vulnerability Prevention via Oligodendrocyte Protection h-c5698ce3 | CXCL10 | promoted | 0.667 | 2026-05-13 | Open → |
| 22 | Oligodendrocyte DNA Repair Enhancement Therapy h-fa7ac9cb | PARP1 and XRCC1 | proposed | 0.665 | 2026-05-13 | Open → |
| 23 | PARP1 Inhibition Blocks Poly(PR)-Triggered DNA Damage and Subsequent p53 Activa… h-737c3be8 | PARP1 | promoted | 0.661 | 2026-05-13 | Open → |
| 24 | Complement C1QA Inhibition Synergizes with PV Interneuron Modulation h-329b1a79 | C1QA, PVALB | proposed | 0.659 | 2026-05-14 | Open → |
| 25 | TREM2 Activation as an Amplification Node for R136S Protection h-69c9d059 | TREM2 | proposed | 0.657 | 2026-05-14 | Open → |
| 26 | Parvalbumin Interneuron Vulnerability Links Lactate Transport to Gamma Oscillat… h-7c93c300 | PVALB, SLC16A1/MCT1 | promoted | 0.656 | 2026-05-16 | Open → |
| 27 | Astrocyte-Microglia Communication Rebalancing via Cytokine Modulation h-89500d80 | IL1A, TNF, C1Q | promoted | 0.655 | 2026-05-16 | Open → |
| 28 | Microbiota-Microglia Axis Modulation h-6f21f62a | Multiple | debated | 0.651 | 2026-05-13 | Open → |
| 29 | Astrocyte APOE4-Specific Lipid Metabolism Correction h-3be15ed2 | APOE | proposed | 0.651 | 2026-05-16 | Open → |
| 30 | Oligodendrocyte Remyelination Enhancement h-e003a35e | TREM2 | proposed | 0.644 | 2026-05-13 | Open → |
| 31 | Dual Calpain/Cathepsin B Inhibition as Primary Neuroprotective Strategy h-699c0d72 | — | promoted | 0.644 | 2026-05-16 | Open → |
| 32 | Mitochondrial NAD+ Salvage Enhancement h-3da804f5 | STING1 | proposed | 0.639 | 2026-05-13 | Open → |
| 33 | Acid-Degradable LNP-Mediated Prenatal CRISPR Intervention for Severe Neurodevel… h-10b5bf6f | SOD1, HTT, TARDBP | proposed | 0.638 | 2026-05-13 | Open → |
| 34 | Selective Neuronal Vulnerability Network Targeting h-0f2b2111 | Cell-type specific vulnerability markers | proposed | 0.638 | 2026-05-13 | Open → |
| 35 | Astrocyte Metabolic Reprogramming via APOE4 Correction h-d8f2bbc9 | APOE | promoted | 0.636 | 2026-05-13 | Open → |
| 36 | TREM2-Dependent Microglial Phagocytosis Acts as a Strain Selection Filter h-dca86efa | TREM2 | proposed | 0.636 | 2026-05-13 | Open → |
| 37 | DLK MAPK Pathway Inhibition to Block Tau-Induced Neurotoxicity Without Directly… h-917f37cf | MAP2K7/MAP3K12 | promoted | 0.634 | 2026-05-13 | Open → |
| 38 | Disease-Associated Microglia Metabolic Reprogramming h-2531ed61 | TREM2 | promoted | 0.631 | 2026-05-16 | Open → |
| 39 | Selective Cholinergic Protection via APP Pathway Modulation h-0d576989 | APP | proposed | 0.629 | 2026-05-13 | Open → |
| 40 | Cardiovascular-Neuroinflammatory Dual Targeting h-6f1e8d32 | TNF/IL6 | debated | 0.627 | 2026-05-16 | Open → |
| 41 | Myelin Sulfatide Restoration h-d9604ebf | GAL3ST1 | promoted | 0.623 | 2026-05-16 | Open → |
| 42 | Microglial ACE Enhancement for Amyloid Clearance h-1e28311b | ACE | proposed | 0.622 | 2026-05-13 | Open → |
| 43 | H7: Enteric Nervous System Alpha-Synuclein Propagation Blocker via Gut Barrier… h-a5186bb8 | IL-22, REG3G, zonulin | promoted | 0.620 | 2026-05-13 | Open → |
| 44 | Cross-Cell Type Synaptic Rescue via Tripartite Synapse Restoration h-019c56c1 | SYN1, SLC1A2, and CX3CR1 | proposed | 0.620 | 2026-05-13 | Open → |
| 45 | CSF Biomarker-Guided ABCA7 Therapeutic Dosing h-bc635955 | ABCA7 with biomarker-guided dosing | promoted | 0.619 | 2026-05-14 | Open → |
| 46 | Lysosomal pH Restoration Upstream of TFEB h-6b394be1 | ATP6V1A | proposed | 0.619 | 2026-05-13 | Open → |
| 47 | BH4 Cofactor Restoration as Primary Driver of >500-Fold Dopamine Elevation h-a01166ee | GCH1, TH, BH4 pathway | proposed | 0.618 | 2026-05-14 | Open → |
| 48 | Perinatal Immune Challenge Prevention h-8f9633d9 | Multiple | debated | 0.616 | 2026-05-16 | Open → |
| 49 | APOE4-Lipid Metabolism Correction h-69bde12f | APOE | debated | 0.610 | 2026-05-16 | Open → |
| 50 | Temporal TFEB Modulation Therapy h-1775578a | TFEB | proposed | 0.609 | 2026-05-16 | Open → |